P1455: FIRST-IN-HUMAN TRIAL OF CB-010, A CRISPR-EDITED ALLOGENEIC ANTI-CD19 CAR -T CELL THERAPY WITH A PD-1 KNOCK OUT, IN PATIENTS WITH RELAPSED OR REFRACTORY B CELL NON-HODGKIN LYMPHOMA (ANTLER STUDY). (23rd June 2022) - Nastoupil, L. J.; O'Brien, S.; Holmes, H. E.; Dsouza, L.; Hart, D.; Matsuda, E.; Satterfield-Ledbetter, T.; Skoble, J.; Garner, E.; Bryan, M.; Kanner, S.; Li, E.; et al.